NASDAQ:HOWL
Analysts review Werewolf Therapeutics Inc’s rating
Daniel Torres
Werewolf Therapeutics Inc’s recent filing unveils that its Director EVNIN LUKE unloaded Company’s shares for reported $57205.0 on Nov 13 ...
HOWL price target predicted to rise nearly 12 in 12 months
Samantha Gray
Investors can speculate about the future of a stock by watching how its insiders buy and sell stocks. Werewolf Therapeutics ...
HOWL’s latest rating updates from top analysts.
Jaxson Clark
Werewolf Therapeutics Inc’s recent filing unveils that its Shareholder MPM Asset Management Investors acquired Company’s shares for reported $5867.0 on ...
Werewolf Therapeutics Inc [HOWL] Investment Guide: What You Need to Know
Roman Campbell
Werewolf Therapeutics Inc’s filing revealed that its Shareholder MPM Asset Management Investors acquired Company’s shares for reported $7928.0 on Oct ...
